文献速递脑血管病

院前卒中量表预测大血管闭塞:系统综述与网络Meta分析

Evaluating Prehospital Stroke Scales for Large Vessel Occlusion: A Systematic Review and Network Meta-Analysis.
PubMed 文献 · Neurology · 2026-02-02

该系统综述与网络Meta分析纳入58项研究、58,381例患者和33个卒中量表,评估院前卒中量表预测大血管闭塞的诊断准确性。各量表汇总敏感度从0.30(HEMIPARESIS)到0.99(LARIO),特异度从0.34(FANG)到0.94(HEMIPLEGIA);LARIO、FPSS、FACE2AD和ACT-FAST的AUC较高。贝叶斯网络Meta分析排名前五为POMONA、NIHSS、sNIHSS EMS、G-FAST和SAFE。

要点

  • 各院前卒中量表预测大血管闭塞的敏感度和特异度差异较大。
  • LARIO、FPSS、FACE2AD和ACT-FAST的汇总AUC较高。
  • 网络Meta分析排名前五为POMONA、NIHSS、sNIHSS EMS、G-FAST和SAFE。

核心结论

  • 多种临床量表可用于院前检测大血管闭塞,但尚需简单、准确且可推广的工具。

研究设计与样本

  • 系统综述与网络Meta分析,纳入58项研究、58,381例患者和33个卒中量表,研究发表于2014至2023年。

主要发现

  • 汇总敏感度从0.30(HEMIPARESIS)到0.99(LARIO),汇总特异度从0.34(FANG)到0.94(HEMIPLEGIA)。
  • LARIO(AUC=0.983)、FPSS(AUC=0.896)、FACE2AD(AUC=0.876)和ACT-FAST(AUC=0.873)的AUC较高。
  • 院前环境中FPSS(AUC=0.896)、FAST VAN(AUC=0.878)和FACE2AD(AUC=0.876)表现较强。
  • 院内环境中LARIO(AUC=0.983)和ACT-FAST(AUC=0.883)准确度最高。
  • 贝叶斯网络Meta分析排名前五为POMONA(SUCRA=0.877)、NIHSS(0.856)、sNIHSS EMS(0.854)、G-FAST(0.823)和SAFE(0.788)。

关键数值与推荐

  • 汇总敏感度范围0.30(HEMIPARESIS)至0.99(LARIO)。
  • 汇总特异度范围0.34(FANG)至0.94(HEMIPLEGIA)。
  • LARIO的AUC=0.983,FPSS的AUC=0.896,FACE2AD的AUC=0.876,ACT-FAST的AUC=0.873。
  • POMONA的SUCRA=0.877,NIHSS的SUCRA=0.856,sNIHSS EMS的SUCRA=0.854。

临床怎么用

  • 院前环境中可优先考虑FPSS、FAST VAN和FACE2AD等表现较强的量表。
  • 院内环境中LARIO和ACT-FAST准确度最高,可辅助识别大血管闭塞。
  • 选择量表时需结合具体临床环境,并关注其敏感度与特异度的平衡。

局限性

  • 研究主要来自北美(50%)和欧洲(26%),中位样本量473例,外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Ischemic stroke remains a leading cause of death and disability worldwide, with large vessel occlusion (LVO) accounting for a disproportionate share of poststroke morbidity. Early identification of LVO is essential for timely intervention with endovascular thrombectomy; however, the clinical scales currently used for triage vary widely in their application and accuracy. This study assesses the diagnostic performance of clinical stroke scales in predicting LVO. METHODS: A systematic review was conducted to identify studies evaluating the diagnostic accuracy of prehospital stroke scales for detecting LVO. Pooled sensitivity and specificity were estimated using a bivariate random-effects model, with diagnostic performance further assessed through summary receiver operating characteristic (ROC) curves and area under the curve (AUC) analysis. A Bayesian network meta-analysis was conducted to rank the scales using surface under the cumulative ranking (SUCRA) probabilities, and post hoc analyses were performed to evaluate publication bias. RESULTS: A total of 58 studies comprising 58,381 patients and 33 unique stroke scales were included in the final analysis. The studies, published between 2014 and 2023, were primarily conducted in North America (50%) and Europe (26%), with a median sample size of 473 participants. Pooled sensitivity ranged from 0.30 (HEMIPARESIS) to 0.99 (LARIO) while specificity varied from 0.34 (FANG) to 0.94 (HEMIPLEGIA). Among the highest-performing scales overall were LARIO (AUC = 0.983), FPSS (AUC = 0.896), FACE2AD (AUC = 0.876), and ACT-FAST (AUC = 0.873). In prehospital settings, FPSS (AUC = 0.896), FAST VAN (AUC = 0.878), and FACE2AD (AUC = 0.876) demonstrated strong performance while LARIO (AUC = 0.983) and ACT-FAST (AUC = 0.883) showed the highest accuracy in hospital settings. Bayesian network meta-analysis identified POMONA (SUCRA = 0.877), NIHSS (0.856), sNIHSS EMS (0.854), G-FAST (0.823), and SAFE (0.788) as the top-ranked scales. Funnel plot analysis revealed minimal publication bias among the most frequently evaluated tools, including RACE, CPSS, and NIHSS. DISCUSSION: Numerous clinical scales are available for detecting LVO in the prehospital setting. While several demonstrate strong performance in specific contexts, there remains a clear need for a simple, accurate, and generalizable tool to reliably identify patients with LVO across diverse clinical environments.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Nawabi NLA, Rivera ER, de Wilde D, et al. Evaluating Prehospital Stroke Scales for Large Vessel Occlusion: A Systematic Review and Network Meta-Analysis. Neurology. 2026. PMID: 41628407. doi:10.1212/WNL.0000000000214484

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。